Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Auto Casualty
Article
Using an Advanced Medical Bill Review Platform to Improve Third Party Outcomes
Some auto casualty insurance carriers’ workflows are missing a key part of an
Mitchell
Article
Using Data Analytics to Optimize Insurance Claims Management
For insurance carriers, finding ways to capitalize on the growing volume and velocity of information being generated and collected in their claims
Mitchell
Article
Mitchell Canadian Collision Summary: Q1 2017
Canadian Appraisal Severity Editor's Note At the request of our customers and f
Mitchell
Article
Mitchell Canadian Collision Summary: Q2 2017
Canadian Appraisal Severity Editor's Note At the reque
Mitchell
Article
Mitchell Collision Repair Industry Data: Q1 2017
Appraisal Values The initial average appraisal value, calculated by combining data from all first and third-party repairable vehicle appr
Mitchell
Article
Mitchell Collision Repair Industry Data: Q2 2017
Adjustments The initial average appraisal value, calculated by combining data from all first and third-party repairable vehicle appraisal